TrialMolecular oncology2022

Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial.

Mariaelena Pierobon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.